Steris: Marginal Gains Capitalized At Higher Rates, Reiterate Buy
STERIS plc (NYSE: STE ) posted Q1 FY'26 numbers in the 1st week of August with several high-quality takeouts. Since my last publication in Sep '23 the business has continued to chugEquity strategist (US Equities)Technical focus on fundamental value drivers of business economics to uncover high probability long-term compounders. Seeking to buy at appropriate prices relative to intrinsic worth. Partners are represented over the cross-section of financial markets, from speculators, hedgers, long-term traders a ...